Mycophenolate Mofetil
Brand name: Mycophenolate Mofetil
Rank #404 of 500 drugs by total cost
$22.0M
Total Cost
152,937
Total Claims
$22.0M
Total Cost
5,248
Prescribers
$144
Cost per Claim
18,710
Beneficiaries
259,728
30-Day Fills
$4,192
Avg Cost/Provider
29
Avg Claims/Provider
About Mycophenolate Mofetil
Mycophenolate Mofetil (sold as Mycophenolate Mofetil) was prescribed 152,937 times by 5,248 Medicare Part D providers in 2023, costing the program $22.0M. At $144 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 401 | Torsemide (Torsemide) | $22.2M | 971,579 |
| 402 | Doxepin Hcl (Doxepin Hcl) | $22.2M | 371,255 |
| 403 | Loteprednol Etabonate (Loteprednol Etabonate) | $22.1M | 85,761 |
| 404 | Mycophenolate Mofetil (Mycophenolate Mofetil) | $22.0M | 152,937 |
| 405 | Tolterodine Tartrate (Tolterodine Tartrate Er) | $21.8M | 178,340 |
| 406 | Chlorthalidone (Chlorthalidone) | $21.8M | 966,780 |
| 407 | Ondansetron (Ondansetron Odt) | $21.5M | 1,261,950 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology